Abstract
Work‐related musculoskeletal disorders (WMSD) are caused by the overuse of muscles in the workplace. Performing repetitive tasks is a primary risk factor for the development of WMSD. Many workers in highly repetitive jobs exhibit muscle pain and decline in handgrip strength, yet the mechanisms underlying these dysfunctions are poorly understood. In our study, rats performed voluntary repetitive reaching and grasping tasks (Task group), while Control group rats did not perform these activities. In the Task group, grip strength and forearm flexor withdrawal threshold declined significantly from week 2 to week 6, compared with these values at week 0 (P < 0.05). Relative muscle weight and muscle fiber cross‐sectional area of flexor digitorum superficialis (FDS) muscles decreased significantly in the Task group, compared with the Control group, at 6 weeks (P < 0.05 and P < 0.01, respectively). Nerve growth factor, glial cell line‐derived neurotrophic factor, and tumor necrosis factor α‐expression in FDS muscles were not significantly different in Control and Task groups at 3 and 6 weeks. At 6 weeks, the Task group had elevated MuRF1 protein levels (P = 0.065) and significant overexpression of the autophagy‐related (Atg) proteins, Beclin1 and Atg5–Atg12, compared with in the Control group (both P < 0.05). These data suggested that long‐term exposure to excessive repetitive motion causes loss of grip strength, muscle pain, and skeletal muscle atrophy. Furthermore, this exposure may enhance protein degradation through both the ubiquitin‐proteasome and autophagy‐lysosome systems, thereby decreasing skeletal muscle mass.
Keywords: autophagy‐lysosome system, grip strength, muscle atrophy, muscle pain, ubiquitin‐proteasome system, work‐related musculoskeletal disorders
Abbreviations
- Atg
autophagy‐related
- Atrogin‐1
muscle atrophy F‐box/Atrogin‐1
- CBB
coomassie brilliant blue
- CSA
cross‐sectional area
- DOMS
delayed‐onset muscle soreness
- EDL
extensor digitorum longus
- FDS
flexor digitorum superficialis
- GDNF
glial cell line‐derived neurotrophic factor
- IL
interleukin
- LC3
microtubule‐associated protein 1 light chain 3
- MuRF1
muscle RING finger 1
- NGF
nerve growth factor
- PVDF
polyvinylidene difluoride
- qRT‐PCR
quantitative reverse transcription PCR
- SEM
standard error of the mean
- TNF
tumor necrosis factor
- WMSD
work‐related musculoskeletal disorders
Work‐related musculoskeletal disorders (WMSD) are defined as injuries or musculoskeletal effects caused by exposure to certain risk factors in the workplace. Risk factors for WMSD include repetition, force, and awkward or static postures. Previous research showed that in highly repetitive jobs (a cycle time < 30 s or more than 50% of the time performing same type of fundamental cycle), there was a 2.8 odds ratio of injury compared with in low repetition jobs 1. Of female workers in highly repetitive jobs, 23% reported muscle pain in forearm and hand muscles 1. Furthermore, women seeking medical care for WMSD of the upper extremities also showed decreased handgrip strength, and these symptoms were related to their levels of perceived physical exertion 2.
Using rat models, previous studies have investigated the pathophysiology of injuries of the upper forelimb caused by voluntary repetitive reaching and grasping tasks 3, 4. Several investigators reported that the repetitive tasks caused decreased grip strength 5, 6, 7, 8, 9. Barbe et al. 5 reported that performance of voluntary repetitive reaching and grasping tasks led to increased levels of tumor necrosis factor (TNF)‐α, interleukin (IL)‐1α, and IL‐1β in rat forearm flexor muscles. Furthermore, this task led to elevated levels of substance P and its preferred receptor, neurokinin‐1, in the spinal cord dorsal horn 10. In addition, previous studies showed that high repetition tasks increased fibrogenic‐related proteins in skeletal muscle or tendon 7, 8, 9. Several inflammatory cytokines, including TNF‐α, IL‐1α, IL‐1β, were implicated in pain. Substance P is another major mediator of neuropathic inflammatory pain. Therefore, muscle pain would be expected to occur in volunteers performing repetitive reaching and grasping tasks. Recently, Xin et al. 11 studied skin pain, often assessed with a von Frey hair test, in a WMSD model. However, according to Nasu et al. 12, it is necessary to use a probe with a diameter of at least 2.6 mm to evaluate the mechanical threshold of skeletal muscle. Thus, while factors affecting decreased grip strength after repetitive reaching and grasping tasks have been proposed in several studies 5, 6, 7, 8, 9, those affecting pain in such models have not been identified. It remains to be demonstrated that a rat model for repetitive tasks exhibits similar muscle pain as that seen in workers with highly repetitive jobs.
In several other animal models, muscle pain was produced by exercise stresses different from the repetitive reaching and grasping tasks. Some animals were forced to exercise by repetition of eccentric contractions. After such exercise, they experienced delayed‐onset muscle soreness (DOMS) and declines in mechanical withdrawal threshold in the muscle 13, 14. In a previous study, physical exercise, including eccentric contractions, induced expression of nerve growth factor (NGF), glial cell line‐derived neurotrophic factor (GDNF), and TNF‐α in skeletal muscle and, consequently, led to decreased muscle mechanical thresholds 13, 15, 16. NGF, produced in skeletal muscle after ischemia 17 or nerve injury, can sensitize muscle nociceptors 18. Like NGF, GDNF is also responsible for growth and maintenance of certain neurons. In rats, injection of either NGF or GDNF into skeletal muscle led to a decline in the mechanical threshold 16, 19. Therefore, we hypothesized that performance of repetitive reaching and grasping tasks by rats would lead to upregulation of NGF, GDNF, and TNF‐α and to declines in mechanical thresholds in muscle.
It is further worth noting that generally, pain reduces muscle strength 20, 21, 22. However, studies showed strong correlations between muscle force and either muscle volume or cross‐sectional area (CSA) 23, 24, 25. Hence, not only muscle pain, but also skeletal muscle atrophy, may be responsible for the decline in grip strength caused by repetitive reaching and grasping tasks. Changes in skeletal muscle mass, in rats performing the tasks, have not been investigated.
Skeletal muscle adaptation depends on dynamic interplay between changes in muscle protein synthesis and degradation. Both the ubiquitin‐proteasome and autophagy‐lysosome systems are involved in the degradation of skeletal muscle proteins.
The ubiquitin‐proteasome system degrades soluble and myofibrillar proteins 26. Specificity of substrate tagging is ensured by ubiquitin ligases. For example, levels of two muscle‐specific ligases, muscle RING finger 1 (MuRF1) and muscle atrophy F‐box/Atrogin‐1 (Atrogin‐1), were increased in several instances of catabolism 27. MuRF1 and Atrogin‐1 are believed to selectively bind substrates for ubiquitination and subsequent degradation by the 26S proteasome. Thus, increased MuRF1 and Atrogin‐1 expression following an atrophy‐inducing stressor is attributed to the shift in protein balance from net synthesis to net degradation 28. The process of autophagy begins with autophagosome formation, in which a double membrane is formed around a portion of the cytoplasm containing proteins and/or organelles. Autophagosome formation is under the control of proteins encoded by autophagy‐related (Atg) genes. In particular, two ubiquitin‐like conjugation systems were described. In the first, the Atg5–Atg12 complex can interact with Atg16 to participate in autophagosome membrane formation. The second involves Atg8, also known in mammals as microtubule‐associated protein 1 light chain 3 (LC3). LC3II was implicated in substrate selection for degradation and in membrane fusion and, when bound to phospholipid, is known as LC3II 29. Among proteins implicated in control of the autophagy process, the Atg6 homolog Beclin1 appears to be central for the initiation of sequestration 30, 31.
In one report, long‐term running exercise led to increased MuRF1 protein expression and proteasome activity 32 and increased levels of Atg proteins Beclin1 and LC3II, suggesting increased basal autophagy 33, in plantaris muscle of mice. Thus, long‐term running exercise is believed to promote muscle protein degradation through these two systems. However, changes, during repetitive reaching and grasping tasks, in molecules involved in muscle protein degradation were not yet investigated.
Therefore, the first purpose of our study was to investigate factors involved in decreased grip strength, from the perspective of muscle pain and skeletal muscle mass, associated with voluntary repetitive reaching and grasping tasks in the rat. The second purpose was to examine key regulators of muscle pain associated with the task. The third purpose was to evaluate repetitive task‐dependent activation of the ubiquitin‐proteasome and autophagy‐lysosome systems. In this study, we chose a rat model not involving use of force. As shown by Barbe et al. 5 and Clark et al. 6, rats performing continued repetitive reaching and grasping tasks (high repetition negligible force model) exhibited dysfunctions similar to those in humans. This indicated that high‐frequency motion, not necessarily involving high force, induces WMSD. Thus, in our study, we investigated the hypothesis that long‐term exposure to excessive repetitive motion would cause loss of grip strength, muscle pain, and skeletal muscle atrophy and, furthermore, that such atrophy would involve enhanced protein degradation through the ubiquitin‐proteasome and autophagy‐lysosome systems.
Materials and methods
Animals
All animal procedures were performed under the animal care guidelines of Nagoya University. A total of 41 female Sprague‐Dawley rats, aged 10 weeks, were used for this study. Rats were from Japan SLC (Hamamatsu, Japan) and were housed under controlled temperature (25 °C) and lighting (8:00–20:00 light) conditions. Rats were divided randomly into food‐restricted control (Control, n = 19) or task (Task, n = 22) groups. Control and Task groups were restricted from food for 5 or 8 weeks. These rats were food deprived so that they maintained 80%–90% of full body weight, as defined by the weights of age‐matched normally fed rats. Rats were weighed weekly and their food was adjusted accordingly 3, 4, 6. After a 2‐week training period (described below) and the first 3 weeks of the Task period (this time is known as ‘3 weeks’ in our study), the rats in each group were further subdivided to perform certain analyses. The reason was to avoid potential artifacts in the muscle tissue analyses introduced by prior behavioral testing. Thus, a subset of the Control group at 3 weeks (n = 6) and Task group at 3 weeks (n = 6) were never subjected to behavioral analysis. This enabled their muscle samples to be used for both histological (i.e., measurements of relative muscle weight and muscle fiber CSA) and molecular biological and biochemical (i.e., mRNA expression relevant to muscle pain, ubiquitin‐proteasomes, and autophagy‐lysosomes) analyses because these rats had no potential effects of behavioral analysis. For rats providing tissue at the 6‐week time point, the type of behavioral testing they had been subjected to determined which types of analyses could be performed on their tissues. Thus, behavioral analysis data (grip strength and pain) were examined only in certain rats and these were measured for the six consecutive weeks of the Task period (i.e., the Control group in which grip strength was measured (n = 6), the Control group in which muscle pain was measured (n = 7), the Task group in which grip strength was measured (n = 6), and the Task group in which muscle pain was measured (n = 10). Grip strength and pain were performed on separate groups of rats but, for each parameter, the same rats were compared each week. For the ‘week 6’ tissue samples, histological analysis (i.e., measurements of relative muscle weight and muscle fiber CSA) and molecular biological and biochemical analyses (i.e., mRNA and protein expression relevant to ubiquitin‐proteasomes and autophagy‐lysosomes) were performed using muscle tissue from rats in which grip strength had been measured. In contrast, NGF, GDNF, and TNF‐α levels were measured using muscle tissue from rats in which muscle pain had been measured. The reason for this was the concern that applying mechanical stimulation to the skeletal muscle, necessary to measure muscle pain, would affect skeletal muscle size. For example, in previous studies, skeletal muscle atrophy was suppressed by mechanical stimulation such as stretching 34, 35. Therefore, we did not want to analyze skeletal muscle size in rats that had been tested for pain. It should be noted that the body weights did not differ between the Control and Task groups throughout the experimental period. Thus, differences in muscle, such as fat content, caused by excessive weight would not have confounded our histological analyses.
Voluntary repetitive reaching and grasping tasks
Rats were placed in the test box, as described by Metz and Whishaw 36. There was a 1.3‐cm‐wide vertical opening in the middle of the front wall enabling rats to reach for pellets placed on a shelf. Food pellets (45 mg; BioServ, Frenchtown, NJ, USA) were dispensed every 15 s during the task. The rats performed the voluntary repetitive reaching and grasping tasks to obtain food pellets (Fig. 1). When a rat appeared likely to react to the pellets, an observer played a sound that was timed with pellet distribution 3, 4. In addition, the observer adjusted the position of the pellet, so that the rats could grip the pellet with only one paw at a time. Control and Task groups were initially trained for 2 weeks to learn the voluntary repetitive reaching and grasping task for obtaining a food pellet. After the initial training period, only the Task group rats performed the repetitive reaching and grasping tasks, for 2 h·day−1, 3 days per week, for 3 or 6 consecutive weeks. An observer counted the number of reaches and grasps, how many food pellets were obtained, and task durations. The task duration was defined as the total time that the rat participated in the task, and was as long as 2 h·day−1. These task parameters were used as the indicators of physical load. As previously described 3, this model used a ‘high repetition, negligible force’ task.
Forelimb grip strength measurement
Rats were lifted by the tail and induced to grasp a rigid bar attached to a digital force gauge (Aikoh Engineering Corporation, Osaka, Japan). Each rat was gently pulled backward by the tail and the tension reading of the digital force gauge, just before the rat released the bar, was defined as grip strength. The test was performed five consecutive times and the highest value from the five trials was recorded as the grip strength.
Withdrawal threshold measurement
Muscular mechanical hyperalgesia was measured as a forearm withdrawal threshold, in response to gradually increasing mechanical forces applied to the forearm flexors [flexor digitorum superficialis (FDS) muscle included]. The method was a modification of that described by Nakano et al. 37 (Fig. 2). Briefly, the head and trunk of the rat were wrapped with a cloth and the rat was suspended in a homemade hammock. We confirmed that, under these conditions, the forelimb position was freely movable. Forearm withdrawal threshold was quantified with a Pressure Application Measurement device (Ugo Basile, Comerio, Italy) equipped with a handmade round‐headed probe (5 mm tip diameter). It has been previously shown that a probe with a tip diameter of 5 mm allows measurements of the muscle mechanical nociceptive threshold 12. The pressure required to elicit forelimb withdrawal was determined, and measurements were taken 5 times at 1‐min intervals. The mean value of these measurements was used as the forearm flexor withdrawal threshold.
Tissue collection
Tissues were collected from a total of 34 rats, from the Control group at 3 weeks (n = 6) and 6 weeks (n = 11) and from the Task group at 3 weeks (n = 6) and 6 weeks (n = 11). This tissue collection was performed 24–36 h after completion of the final task, to ensure that measurements reflected the chronic effects of long‐term exposure to repetitive motion, rather than immediate effects of the last exercise. Similarly, in a previous study 5, muscle tissue was collected 18–36 h after the final task. Rats were euthanized by pentobarbital overdose (Nembutal; 120 mg·kg−1). FDS muscle from each reaching limb was harvested immediately after euthanasia. After harvesting, each muscle sample was cut into two pieces that were preserved, respectively, for molecular biological and biochemical analyses and histological analysis. Specifically, muscles were cut across the midbelly portion and the distal part was used for molecular biological and biochemical analyses. The proximal part was used for histological analysis. The midbelly portion of the muscle was cut to measure the CSA at the site where the muscle fiber became thickest 38, 39. Muscle samples were flash‐frozen and stored at −80 °C until analyzed.
Morphological analysis of FDS muscles
A total of 24 frozen muscle samples were analyzed, from the Control group at 3 weeks (n = 6) and 6 weeks (n = 6) and from the Task group at 3 weeks (n = 6) and 6 weeks (n = 6). These samples were embedded in optimal cutting temperature compound (Sakura Finetek, Torrance, CA, USA), and cross sections (8 μm) were cut with a cryostat (CM1510S; Leica, Wetzlar, Germany). These muscle cryosections were stained with hematoxylin and eosin (H&E), and images of the stained samples were obtained with an optical microscope (BZ‐9000; KEYENCE, Osaka, Japan). Muscle fiber CSAs were measured from captured images using image j software (National Institutes of Health, Bethesda, MD, USA). Analysis was performed on at least 200 muscle fibers per muscle, and these values were averaged.
RNA isolation
Muscles were homogenized in ice‐cold Trizol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After incubation for 5 min at room temperature, the mixture was centrifuged at 15 000 g for 10 min at 4 °C. The supernatant was transferred to a tube, a 1/5 volume of chloroform was added, and sample was mixed. The mixture was incubated for 5 min at room temperature, then centrifuged at 15 000 g for 10 min at 4 °C. The aqueous layer was transferred to another tube and mixed with 0.8 volume of isopropanol by pipetting. The mixture was incubated for 10 min at room temperature, then centrifuged at 15 000 g for 10 min at 4 °C. The RNA pellet was washed with 70% ethanol and centrifuged at 15 000 g for 10 min at 4 °C. RNA was dissolved in 20 μL RNase‐free water with RNase inhibitor (final concentration 2 μg·μL−1) and further subjected to DNase treatment and reverse transcription using a ReverTra Ace qPCR RT Master Mix (Toyobo, Osaka, Japan).
Real‐time quantitative reverse transcription PCR
Quantitation of gene expression was determined by real‐time quantitative reverse transcription PCR (qRT‐PCR). qRT‐PCR mixture contained 2 μL cDNA, 10 μL TaqMan® Fast Advanced Master Mix (Life Technologies, Carlsbad, CA, USA), and 1 μL primers. The PCR analysis was performed with a StepOnePlus Real‐Time PCR system (Applied Biosystems, Foster City, CA, USA), using the ΔΔCt method. The primers were NGF (Ngf, Rn01533872_m1), GDNF (Gdnf, Rn00569510_m1), MuRF1 (Trim63, Rn00590197_m1), Atrogin‐1 (Fbxo32, Rn00591730_m1), Beclin1 (Becn1, Rn00586976_m1), Atg5 (Atg5, Rn01767063_m1), LC3 (Anxa3, Rn00563181_m1), and β‐actin (Actb, Rn00667869_m1), all from TaqMan Gene Expression Assays (Life Technologies). β‐Actin was used as an endogenous control to normalize results for each sample.
Protein isolation
Frozen muscle samples were homogenized in RIPA buffer plus 10% protease inhibitor cocktail (1 mg protein/10 ml RIPA), tissue lysates were centrifuged at 14 000 g for 10 min, and the supernatants were collected. Total protein was determined using the BCA‐200 protein assay kit (Pierce, Rockford, IL, USA).
Western blot analysis
After measuring total protein content, each extract was adjusted to a concentration of 2 μg·μL−1 with an appropriate volume of RIPA buffer for SDS/PAGE. Lysates were mixed with equal volumes of EzApply (Atto, Tokyo, Japan) containing 100 mm Tris/HCl buffer (pH: 8.8), 2% SDS, 20% sucrose, 0.06% bromophenol blue, and 100 mm DTT and were heated at 95 °C for 5 min. For SDS/PAGE, 15–30 μL aliquots of samples were loaded into individual lanes and separated on a precast polyacrylamide gel (10%–18%; Bio‐Rad, Hercules, CA, USA) at a constant voltage of 200 V for 30–45 min. Protein bands were then transferred to a 0.2‐μm polyvinylidene difluoride (PVDF) membrane (Bio‐Rad) by electroblotting at a constant current of 1.3 A for 5 or 7 min, using a rapid transfer system (Trans‐Blot Turbo; Bio‐Rad). After transfer, western blotting was performed with a protein detection system (SNAP i.d. 2.0; Merck Millipore, Billerica, MA, USA). Blots were blocked against nonspecific reactions with 0.5% (w/v) nonfat‐dried milk or 1% (w/v) bovine serum albumin, diluted in Tris‐buffered saline containing either 0.1% (v/v) Tween 20 (TBS‐T), or with PVDF Blocking Reagent (Can Get Signal; Toyobo). Blots were then incubated overnight at 4 °C with antibodies directed against NGF (sc‐548; Santa Cruz Biotechnology, Santa Cruz, CA, USA), GDNF (sc‐328, Santa Cruz Biotechnology), MuRF1 (ab77577; Abcam, Cambridge, MA, USA), Beclin1 (PD017; MBL International Corporation, Nagoya, Japan), or Atg5–Atg12 (PM050; MBL International Corporation). Blots were then washed, incubated with the appropriate secondary antibodies, and washed again. Stained bands were then visualized using the ECL Prime Western Blotting Detection System (RPN2232; GE Healthcare Japan, Tokyo, Japan) according to the manufacturer's instructions. Images were captured and documented with a CCD system (Light Capture II; Atto). After measurements, membranes were stripped using stripping buffer (Restore Plus, Pierce, Rockford, IL, USA) and stained with coomassie brilliant blue (CBB) to verify equal loading in all lanes 40. Densitometric analysis of these images was performed using imaging analysis software (CS analyzer 3.0; Atto) and normalized to the optical density of the CBB stain of each band.
ELISA
Tissue lysates from the Control group at 6 weeks (n = 5) and Task group at 6 weeks (n = 5) were analyzed using an ELISA kit for rat TNF‐α (Ray Biotech, Norcross, GA, USA), following the manufacturer's protocol. The minimum assay sensitivity for TNF‐α was 25 pg·mL−1. Data (pg protein) were normalized to μg total protein.
Statistical analysis
Values are presented as means ± standard error of the mean (SEM). Comparison of body weights, grip strengths, and mechanical hyperalgesia values was made by two‐way repeated‐measures ANOVA, followed by Holm–Sidak multiple comparison tests. Other comparisons were made using Student's t‐test, for time‐matched data from two groups. For transparency, both significant differences (P < 0.05) and trends (0.05 ≤ P < 0.1) are reported, where appropriate. A P value of < 0.05 was considered significant. Data were analyzed using sigmastat 4.0 statistical software (Systat Software Inc., San Jose, CA, USA).
Results
Parameters from the voluntary repetitive reaching and grasping task
The rats performed ~ 4000 reaches and grasps during the first week and ~ 2000 additional reaches and grasps during each subsequent week (Table 1). As a result, the total number of reaches and grasps throughout the experimental period exceeded 14 000. There were more reaches and grasps during the first week, compared with other weeks, because the rats attempted the task even when pellets were not delivered. Beginning in the second week, rats attempted the reach only when pellets were distributed. In total, the rats obtained ~ 1100 food pellets per week. Thus, the total number of food pellets obtained reached ~ 6600 throughout the experimental period. The rats participated in the task for an average of ~ 5.6 h each week, or ~ 34 h throughout the 6‐week experiment.
Table 1.
1 week | 2 weeks | 3 weeks | 4 weeks | 5 weeks | 6 weeks | |
---|---|---|---|---|---|---|
Total reaches and grasps (n) | 4019.0 ± 533.5 | 6682.2 ± 775.5 | 8909.0 ± 974.9 | 10904.2 ± 1161.1 | 12853.5 ± 1313.7 | 14758.3 ± 1459.7 |
Total food pellets obtained (n) | 1047.7 ± 60.3 | 2117.8 ± 88.1 | 3267.0 ± 116.8 | 4355.0 ± 176.1 | 5457.5 ± 235.4 | 6579.2 ± 292.8 |
Total task duration (h) | 5.6 ± 0.3 | 11.2 ± 0.5 | 17.0 ± 0.7 | 22.6 ± 1.0 | 28.2 ± 1.2 | 33.9 ± 1.3 |
Data are presented as mean ± SEM.
Body weight and grip strength
Body weights gradually increased in both Control and Task groups from week 0 (204.7 ± 2.7 and 215.3 ± 2.4 g, respectively) to week 6 (231.7 ± 6.1 and 237.5 ± 3.0 g, respectively). There were no significant differences in body weight between Control and Task groups. In the Control group, grip strengths did not change, compared with those at week 0, throughout the experimental period (Fig. 3). In the Task group, grip strengths declined significantly from week 2 to week 6, compared with at week 0 (P < 0.05), and were significantly lower than in the Control group at 6 weeks (P < 0.01). Grip strengths of the Task group decreased rapidly until week 3 and maintained an ~ 25% decrease, compared with initial values, from week 3 to week 5. The maximum decrease in grip strength in the Task group was evident at 6 weeks, a 32.4% decrease.
Forearm flexor withdrawal threshold
Muscle mechanical hyperalgesia was measured as forearm flexor withdrawal threshold values. In the Control group, forearm flexor withdrawal thresholds did not change, compared with those at week 0 (Fig. 4). In the Task group, forearm flexor withdrawal thresholds declined significantly from week 3 to week 6, compared with initial values (P < 0.05). These values were significantly lower than those in the Control group from week 2 to week 6 (P < 0.05). Forearm flexor withdrawal threshold values for rats in the Task group were gradually decreased up to 6 weeks. The maximum decrease in forearm flexor withdrawal threshold in the Task group was that measured at 6 weeks, a decrease of 11.0%, compared with initial values.
Morphological analysis of FDS muscle
Relative muscle weight (ratio of muscle wet weight normalized to body weight) and muscle fiber CSA values of FDS were not significantly different between the two groups at 3 weeks (Fig. 5A,B). However, both values were significantly lower in the Task group than in the Control group at 6 weeks (P < 0.05 and P < 0.01, respectively).
NGF, GDNF, and TNF‐α expression in FDS muscle
The neurotrophic factors NGF and GDNF and the inflammatory cytokine TNF‐α have been implicated in muscle mechanical hyperalgesia 16, 19, 41, 42. We found no significant differences, between Control and Task groups, in NGF or GDNF mRNA levels at 3 and 6 weeks (Fig. 6A,B). Consistent with this, western blotting showed no differences in NGF and GDNF protein levels in the two groups at 6 weeks (Fig. 6C). There were also no differences in TNF‐α levels, determined by ELISA, in the two groups at 6 weeks (Fig. 7).
Expression of ubiquitin‐proteasome‐ and autophagy‐lysosome‐related proteins in FDS muscle
MuRF1 and Atrogin‐1 were identified as two muscle‐specific E3 ubiquitin ligases, part of the ubiquitin‐proteasome pathway, that were increased transcriptionally in skeletal muscle under atrophy‐inducing conditions. Beclin1 mediates the accumulation of Atg proteins, such as the Atg5–Atg12 conjugation and LC3 conjugation systems, located in preautophagosomal structures. Such factors are considered essential for formation of the autophagic vesicle and for triggering autophagy and phagophore formation. At 3 weeks, expression of E3 ubiquitin ligases and Atg genes was not significantly different in the Control and Task groups (Fig. 8A). At 6 weeks, the Task group had significantly higher mRNA levels of MuRF1 and Beclin1, compared with the Control group (P < 0.05; Fig. 8B). The Task group also had higher levels of Atg5 mRNA (P = 0.071). Based on these qRT‐PCR results, we examined protein levels, at 6 weeks, of only those molecules showing differences in mRNA expression in the two groups.
By western blotting, rats in the Task group had higher levels of MuRF1 protein than those in the Control group at 6 weeks (P = 0.065; Fig. 9). The Task group also had significant overexpression of the Atg proteins Beclin1 and Atg5–Atg12, relative to the Control group, at 6 weeks (both P < 0.05).
Discussion
Change in grip strength across 6 weeks
It was reported that continuing highly repetitive (at least once every 15 s) reaching and grasping tasks for 2 h·day−1, 3 days per week, decreased forearm grip strength in rats, beginning at 6 weeks 5, 43. These previous studies were not designed to detect an effect at 3 weeks; though, Coq et al. did include a 1‐week timepoint. Therefore, in our experiment, we followed previously described methodology but investigated changes in grip strength in more detail, including at 2‐ and 3‐week timepoints. We observed, for the first time, that the decline in grip strength caused by the repetitive tasks occurred earlier than the previous study was able to discern.
Muscle mechanical hyperalgesia caused by repetitive reaching and grasping tasks
We found, also for the first time, that repetitive reaching and grasping tasks caused muscle mechanical hyperalgesia in the rats beginning at 2 weeks. In humans, previous research showed that 23% of female workers in highly repetitive jobs reported muscle pain in the forearm and hand muscles 1. In rats, it was shown that performance of a high repetition (at least once every 15 s) handle‐pulling (force criterion 60 ± 5% of maximum voluntary force) task resulted in decreased withdrawal threshold values in the forepaws at 6 weeks 44. Other animal studies showed that skin pain resulted from highly repetitive tasks, with even higher force than those used in our experiment 45. Our study showed that forearm flexor withdrawal thresholds were significantly decreased from week 3 to week 6, compared with at week 0. These values were significantly lower in the Task than in the Control group from week 2 to week 6. Based on these results, we determined that a rat model of voluntary repetitive reaching and grasping tasks induced musculoskeletal disorders with forearm muscle pain.
Factors associated with loss of grip strength
Examining the relationship between loss of grip strength and muscle pain, Beyreuther et al. 46 reported that intramuscular injection of TNF‐α caused muscle pain and decreased grip strength in rats. These investigators also showed that intramuscularly injected lacosamide or gabapentin, both having antihyperalgesic effects, improved grip strength in the presence of intramuscularly injected TNF‐α in rats. Thus, muscle pain was a contributing factor in the declined grip strength. In our study, declines in both grip strength and forearm flexor withdrawal in the Task group occurred from week 2 to week 6. These results indicated that one of the potential factors in the decline in grip strength caused by repetitive reaching and grasping tasks was muscle pain. Additional factors, relevant to extracellular matrix proteins and fibrosis, were implicated in repetitive reaching and grasping tasks. Abdelmagid et al. 7 reported an increase in collagen type I in skeletal muscle in rats performing the reaching and grasping tasks for 9 weeks. Frara et al. 47 observed increased matrix metalloproteinase levels in skeletal muscle of rats performing the tasks for 3 or 6 weeks. Cabrera et al. 48 showed increased collagen type I in skeletal muscle after repetitive reaching and grasping tasks, and attributed muscle fibrosis to the muscle weakness. In our study, the grip strength of rats in the Task group was lowest at 6 weeks. We observed no morphological changes in FDS muscle at 3 weeks in the Task group rats, compared with the Control group. However, relative muscle weight and muscle fiber CSA of FDS muscle were significantly decreased in Task group rats at 6 weeks. Previous studies indicated a strong correlation between muscle force and muscle volume or CSA 23, 24, 25. Thus, our findings suggested that the loss of grip strength in the Task group at 6 weeks may have been caused not only by muscle mechanical hyperalgesia, but also by muscle atrophy.
Molecular mechanisms underlying FDS muscle atrophy
The balance between protein synthesis and degradation determines whether a muscle undergoes hypertrophy or atrophy. It was previously demonstrated that chronic low‐frequency stimulation (10 Hz, 10 h·day−1) decreased rat extensor digitorum longus (EDL) muscle weight after 4 weeks 49. Katzeff et al. 50 reported, using rats, that long‐term (4 weeks) voluntary wheel running decreased protein synthesis rates of the gastrocnemius, but not the soleus, muscle. Cunha et al. reported that a single session of running exercise, until exhaustion, in mice activated the 26S proteasome, leading to protein degradation in the plantaris muscle immediately after exercise. This was no longer activated at 48 h after the exercise session 32. Moreover, these investigators reported that the effects of long‐term (8 weeks) running exercise in mice, also activation of the 26S proteasome in plantaris muscle, persisted until even 48 h after the last exercise. Hence, in fast‐twitch muscles, long‐term repetitive low‐intensity muscle contraction may cause skeletal muscle atrophy by decreasing protein synthesis and increasing protein degradation. FDS muscle in the rat is known to have a high content of fast‐twitch fibers 51. Overall, the FDS muscle atrophy induced by long‐term repetitive reaching and grasping tasks (i.e., long‐term repetitive muscle contraction) likely resulted from decreased protein synthesis and increased protein degradation.
Two major protein degradation pathways, the ubiquitin‐proteasome and autophagy‐lysosome systems, are activated during muscle atrophy and contribute, to varying extents, to the loss of muscle mass. In the ubiquitin‐proteasome system, E3 ubiquitin ligase (MuRF1) can negatively regulate skeletal muscle mass. Long‐term (8 weeks) running exercise in mice elicited increased MuRF1 protein expression and 26S proteasome activity in plantaris muscle 32. Several studies showed that excessive autophagy activation aggravated muscle wasting 52, 53, 54, 55. Long‐term (4 weeks) voluntary wheel running in mice led to increased expression of Beclin1 and LC3II proteins in plantaris muscle 33. Our results showed that long‐term (6 weeks) repetitive reaching and grasping tasks increased expression of MuRF1, Beclin1, and Atg5–Atg12 proteins, suggesting induction of the ubiquitin‐proteasome and autophagy‐lysosome systems in FDS muscle. Moreover, overexpression of MuRF1, Beclin1, and Atg5, at both mRNA and protein levels, coincided temporally with FDS muscle atrophy in the Task group at 6 weeks. Consequently, we propose that activation of the ubiquitin‐proteasome and autophagy‐lysosome systems contributed to FDS muscle atrophy in the Task group.
Relationship between muscle mechanical hyperalgesia and NGF, GDNF, and TNF‐α levels in FDS muscle
Nerve growth factor, GDNF, and TNF‐α produced muscle mechanical hyperalgesia when injected into skeletal muscle 16, 19, 41, 42. In addition, upregulation of NGF and GDNF in EDL muscle was essential to mechanical hyperalgesia in an animal model of DOMS, caused by repeated lengthening contractions 15, 16. DOMS after intense acute swimming, leading to upregulated TNF‐α in soleus muscle, was required for mechanical hyperalgesia 11. Accordingly, we measured NGF, GDNF, and TNF‐α levels in FDS muscle to investigate the mechanism of muscle mechanical hyperalgesia caused by continuing repetitive reaching and grasping tasks. Barbe et al. reported that performance of voluntary repetitive reaching and grasping tasks increased TNF‐α levels in rat forearm flexor muscle at 8, but not at 6 weeks 5, 43. In our study, NGF, GDNF, and TNF‐α mRNA and protein levels in the Task group were not significantly increased at 3 or 6 weeks, times when muscle mechanical hyperalgesia occurred. The observation that TNF‐α protein levels did not change in FDS muscle before 8 weeks was consistent with previous findings 5, 43. Therefore, we concluded that muscle mechanical hyperalgesia, resulting from continuing repetitive reaching and grasping tasks from week 3 to week 6, may not have been caused by NGF, GDNF, or TNF‐α. This interpretation is consistent with those of Xin et al. 11, who reported that inflammation and pain in a WMSD model (albeit using a different force magnitude from that in our study, i.e., a difference in intensity in task performance) do not involve the same pathway. Elliott et al. 10 showed that performance of voluntary repetitive reaching and grasping tasks increased levels of substance P and its preferred receptor, neurokinin‐1, in the spinal cord dorsal horn at 6 weeks. Intense noxious stimuli induce substance P release from the central terminals of dorsal root ganglion neurons. Substance P then binds to the neurokinin 1 receptor and sensitizes dorsal horn neurons. Thus, central sensitization may have contributed to the muscle pain in rats performing the voluntary repetitive reaching and grasping tasks. Further study will be necessary, investigating the roles of not only skeletal muscle, but also the central nervous system, in muscle pain caused by repetitive tasks.
In conclusion, our study demonstrated that long‐term exposure to excessive repetitive motion caused loss of grip strength, muscle pain, and skeletal muscle atrophy. These findings indicated that muscle pain can trigger a loss of grip strength within a relatively short experimental period and that skeletal muscle atrophy and muscle pain are both involved. Furthermore, such exposures may enhance protein degradation through the ubiquitin‐proteasome and autophagy‐lysosome systems, thereby decreasing skeletal muscle mass.
Author contributions
MF, SS, MI, and TI conceived and designed the project. MF, MI, YA, NY, and KH acquired the data. MF, SS, and MI analyzed and interpreted the data and wrote the manuscript.
Acknowledgements
The authors are grateful to Yu‐Ting Cheng (Nagoya University Hospital) and Yuki Ogawa (Nagoya City Rehabilitation Center) for technical assistance in performing the experiments. This work was supported in part by a grant from A‐kit Co., Ltd., and a grant from the Public Advertisement Research Project of Nihon Fukushi University.
References
- 1. Ranney D, Wells R and Moore A (1995) Upper limb musculoskeletal disorders in highly repetitive industries: precise anatomical physical findings. Ergonomics 38, 1408–1423. [DOI] [PubMed] [Google Scholar]
- 2. Alperovitch‐Najenson D, Carmeli E, Coleman R and Ring H (2004) Handgrip strength as a diagnostic tool in work‐related upper extremity musculoskeletal disorders in women. Sci World J 4, 111–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Barbe MF, Barr AE, Gorzelany I, Amin M, Gaughan JP and Safadi FF (2003) Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 21, 167–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Clark BD, Barr AE, Safadi FF, Beitman L, Al‐Shatti T, Amin M, Gaughan JP and Barbe MF (2003) Median nerve trauma in a rat model of work‐related musculoskeletal disorder. J Neurotrauma 20, 681–695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Barbe MF, Elliott MB, Abdelmagid SM, Amin M, Popoff SN, Safadi FF and Barr AE (2008) Serum and tissue cytokines and chemokines increase with repetitive upper extremity tasks. J Orthop Res 26, 1320–1326. [DOI] [PubMed] [Google Scholar]
- 6. Clark BD, Al‐Shatti TA, Barr AE, Amin M and Barbe MF (2004) Performance of a high‐repetition, high‐force task induces carpal tunnel syndrome in rats. J Orthop Sports Phys Ther 34, 244–253. [DOI] [PubMed] [Google Scholar]
- 7. Abdelmagid SM, Barr AE, Rico M, Amin M, Litvin J, Popoff SN, Safadi FF and Barbe MF (2012) Performance of repetitive tasks induces decreased grip strength and increased fibrogenic proteins in skeletal muscle: role of force and inflammation. PLoS ONE 7, e38359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Gao HGL, Fisher PW, Lambi AG, Wade CK, Barr‐Gillespie AE, Popoff SN and Barbe MF (2013) Increased serum and musculotendinous fibrogenic proteins following persistent low‐grade inflammation in a rat model of long‐term upper extremity overuse. PLoS ONE 8, e71875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Fedorczyk JM, Barr AE, Rani S, Gao H, Amin M, Amin S, Litvin J and Barbe MF (2010) Exposure dependent increases in IL‐1 beta, substance P, CTGF and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J Orthoped Res 28, 298–301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Elliott MB, Barr AE and Barbe MF (2009) Spinal substance P and neurokinin‐1 increase with high repetition reaching. Neurosci Lett 454, 33–37. [DOI] [PubMed] [Google Scholar]
- 11. Xin DL, Hadrévi J, Elliott ME, Amin M, Harris MY, Barr‐Gillespie AE and Barbe MF (2017) Effectiveness of conservative interventions for sickness and pain behaviors induced by a high repetition high force upper extremity task. BMC Neurosci 18, 36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Nasu T, Taguchi T and Mizumura K (2010) Persistent deep mechanical hyperalgesia induced by repeated cold stress in rats. Eur J Pain 14, 236–244. [DOI] [PubMed] [Google Scholar]
- 13. Borghi SM, Zarpelon AC, Pinho‐Ribeiro FA, Cardoso RDR, Martins‐Pinge MC, Tatakihara RI, Cunha TM, Ferreira SH, Cunha FQ, Casagrande R et al (2014) Role of TNF‐alpha/TNFR1 in intense acute swimming‐induced delayed onset muscle soreness in mice. Physiol Behav 128, 277–287. [DOI] [PubMed] [Google Scholar]
- 14. Taguchi T, Matsuda T, Tamura R, Sato J and Mizumura K (2005) Muscular mechanical hyperalgesia revealed by behavioural pain test and c‐Fos expression in the spinal dorsal horn after eccentric contraction in rats. J Physiol 564, 259–268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Murase S, Terazawa E, Hirate K, Yamanaka H, Kanda H, Noguchi K, Ota H, Queme F, Taguchi T and Mizumura K (2013) Upregulated glial cell line‐derived neurotrophic factor through cyclooxygenase‐2 activation in the muscle is required for mechanical hyperalgesia after exercise in rats. J Physiol 591, 3035–3048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Murase S, Terazawa E, Queme F, Ota H, Matsuda T, Hirate K, Kozaki Y, Katanosaka K, Taguchi T, Urai H et al (2010) Bradykinin and nerve growth factor play pivotal roles in muscular mechanical hyperalgesia after exercise (delayed‐onset muscle soreness). J Neurosci 30, 3752–3761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Turrini P, Gaetano C, Antonelli A, Capogrossi MC and Aloe L (2002) Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett 323, 109–112. [DOI] [PubMed] [Google Scholar]
- 18. Amano T, Yamakuni T, Okabe N, Sakimura K and Takahashi Y (1991) Production of nerve growth factor in rat skeletal muscle. Neurosci Lett 132, 5–7. [DOI] [PubMed] [Google Scholar]
- 19. Murase S, Kato K, Taguchi T and Mizumura K (2014) Glial cell line‐derived neurotrophic factor sensitized the mechanical response of muscular thin‐fibre afferents in rats. Eur J Pain 18, 629–638. [DOI] [PubMed] [Google Scholar]
- 20. Henriksen M, Rosager S, Aaboe J, Graven‐Nielsen T and Bliddal H (2011) Experimental knee pain reduces muscle strength. J Pain 12, 460–467. [DOI] [PubMed] [Google Scholar]
- 21. Park J and Hopkins JT (2013) Induced anterior knee pain immediately reduces involuntary and voluntary quadriceps activation. Clin J Sport Med 23, 19–24. [DOI] [PubMed] [Google Scholar]
- 22. Son SJ, Kim H, Seeley MK, Feland JB and Hopkins JT (2016) Effects of transcutaneous electrical nerve stimulation on quadriceps function in individuals with experimental knee pain. Scand J Med Sci Sports 26, 1080–1090. [DOI] [PubMed] [Google Scholar]
- 23. Bamman MM, Newcomer BR, Larson‐Meyer DE, Weinsier RL and Hunter GR (2000) Evaluation of the strength‐size relationship in vivo using various muscle size indices. Med Sci Sports Exerc 32, 1307–1313. [DOI] [PubMed] [Google Scholar]
- 24. Blazevich AJ, Coleman DR, Horne S and Cannavan D (2009) Anatomical predictors of maximum isometric and concentric knee extensor moment. Eur J Appl Physiol 105, 869–878. [DOI] [PubMed] [Google Scholar]
- 25. Fukunaga T, Miyatani M, Tachi M, Kouzaki M, Kawakami Y and Kanehisa H (2001) Muscle volume is a major determinant of joint torque in humans. Acta Physiol Scand 172, 249–255. [DOI] [PubMed] [Google Scholar]
- 26. Solomon V and Goldberg AL (1996) Importance of the ATP‐ubiquitin‐proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271, 26690–26697. [DOI] [PubMed] [Google Scholar]
- 27. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K et al (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704–1708. [DOI] [PubMed] [Google Scholar]
- 28. Bodine SC and Baehr LM (2014) Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin‐1. Am J Physiol Endocrinol Metab 307, E469–E484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Nakatogawa H, Ichimura Y and Ohsumi Y (2007) Atg8, a ubiquitin‐like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell 130, 165–178. [DOI] [PubMed] [Google Scholar]
- 30. Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T and Ohsumi Y (2001) The pre‐autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 20, 5971–5981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Tassa A, Roux MP, Attaix D and Bechet DM (2003) Class III phosphoinositide 3‐kinase–Beclin1 complex mediates the amino acid‐dependent regulation of autophagy in C2C12 myotubes. Biochem J 376, 577–586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Cunha TF, Moreira JB, Paixao NA, Campos JC, Monteiro AW, Bacurau AV, Bueno CR Jr, Ferreira JC and Brum PC (2012) Aerobic exercise training upregulates skeletal muscle calpain and ubiquitin‐proteasome systems in healthy mice. J Appl Physiol 112, 1839–1846. [DOI] [PubMed] [Google Scholar]
- 33. Lira VA, Okutsu M, Zhang M, Greene NP, Laker RC, Breen DS, Hoehn KL and Yan Z (2013) Autophagy is required for exercise training‐induced skeletal muscle adaptation and improvement of physical performance. FASEB J 27, 4184–4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Kimura S, Inaoka PT and Yamazaki T (2012) Influence of passive stretching on inhibition of disuse atrophy and hemodynamics of rat soleus muscle. J Jpn Phys Ther Assoc 15, 9–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Agata N, Sasai N, Inoue‐Miyazu M, Kawakami K, Hayakawa K, Kobayashi K and Sokabe M (2009) Repetitive stretch suppresses denervation‐induced atrophy of soleus muscle in rats. Muscle Nerve 39, 456–462. [DOI] [PubMed] [Google Scholar]
- 36. Metz GA and Whishaw IQ (2000) Skilled reaching an action pattern: stability in rat (Rattus norvegicus) grasping movements as a function of changing food pellet size. Behav Brain Res 116, 111–122. [DOI] [PubMed] [Google Scholar]
- 37. Nakano J, Sekino Y, Hamaue Y, Sakamoto J, Yoshimura T, Origuchi T and Okita M (2012) Changes in hind paw epidermal thickness, peripheral nerve distribution and mechanical sensitivity after immobilization in rats. Physiol Res 61, 643–647. [DOI] [PubMed] [Google Scholar]
- 38. Miyazaki M, Noguchi M and Takemasa T (2008) Intermittent reloading attenuates muscle atrophy through modulating Akt/mTOR pathway. Med Sci Sports Exerc 40, 848–855. [DOI] [PubMed] [Google Scholar]
- 39. Ishihara A, Kawano F, Ishioka N, Oishi H, Higashibata A, Shimazu T and Ohira Y (2004) Effects of running exercise during recovery from hindlimb unloading on soleus muscle fibers and their spinal motoneurons in rats. Neurosci Res 48, 119–127. [DOI] [PubMed] [Google Scholar]
- 40. Welinder C and Ekblad L (2011) Coomassie staining as loading control in western blot analysis. J Proteome Res 10, 1416–1419. [DOI] [PubMed] [Google Scholar]
- 41. Hoheisel U, Unger T and Mense S (2005) Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat. Pain 114, 168–176. [DOI] [PubMed] [Google Scholar]
- 42. Svensson P, Cairns BE, Wang K and Arendt‐Nielsen L (2003) Injection of nerve growth factor into human masseter muscle evokes long‐lasting mechanical allodynia and hyperalgesia. Pain 104, 241–247. [DOI] [PubMed] [Google Scholar]
- 43. Coq JO, Barr AE, Strata F, Russier M, Kietrys DM, Merzenich MM, Byl NN and Barbe MF (2009) Peripheral and central changes combine to induce motor behavioral deficits in a moderate repetition task. Exp Neurol 220, 234–245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Elliott MB, Barr AE, Clark BD, Amin M, Amin S and Barbe MF (2009) High force reaching task induces widespread inflammation, increased spinal cord neurochemicals and neuropathic pain. Neuroscience 158, 922–931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Fisher PW, Zhao Y, Rico MC, Massicotte VS, Wade CK, Litvin J, Bove GM, Popoff SN and Barbe MF (2015) Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury. J Cell Commun Signal 9, 37–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Beyreuther BK, Geis C, Stohr T and Sommer C (2007) Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology 52, 1312–1317. [DOI] [PubMed] [Google Scholar]
- 47. Frara N, Abdelmagid SM, Tytell M, Amin M, Popoff SN, Safadi FF and Barbe MF (2016) Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping. BMC Musculoskelet Disord 17, 34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Cabrera D, Gutiérrez J, Cabello‐Verrugio C, Morales MG, Mezzano S, Fadic R, Casar JC and Hancke JL (2014) Brandan E (2014) Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis. Skelet Muscle 4, 6. PMID: 24655808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Delp MD and Pette D (1994) Morphological changes during fiber type transitions in low‐frequency‐stimulated rat fast‐twitch muscle. Cell Tissue Res 277, 363–371. [DOI] [PubMed] [Google Scholar]
- 50. Katzeff HL, Ojamaa KM and Klein I (1995) The effects of long‐term aerobic exercise and energy restriction on protein synthesis. Metabolism 44, 188–192. [DOI] [PubMed] [Google Scholar]
- 51. Delp MD and Duan C (1996) Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 80, 261–270. [DOI] [PubMed] [Google Scholar]
- 52. Jannig PR, Moreira JB, Bechara LR, Bozi LH, Bacurau AV, Monteiro AW, Dourado PM, Wisloff U and Brum PC (2014) Autophagy signaling in skeletal muscle of infarcted rats. PLoS ONE 9, e85820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J et al (2007) FoxO3 controls autophagy in skeletal muscle in vivo . Cell Metab 6, 458–471. [DOI] [PubMed] [Google Scholar]
- 54. Penna F, Costamagna D, Pin F, Camperi A, Fanzani A, Chiarpotto EM, Cavallini G, Bonelli G, Baccino FM and Costelli P (2013) Autophagic degradation contributes to muscle wasting in cancer cachexia. Am J Pathol 182, 1367–1378. [DOI] [PubMed] [Google Scholar]
- 55. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH and Goldberg AL (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6, 472–483. [DOI] [PubMed] [Google Scholar]